Results 31 to 40 of about 190,265 (268)
Mediterranean Journal of Hematology and Infectious Diseases, 2023 Background and aim: Thrombocytopenia in the course of Epstein-Barr virus mononucleosis is well-known; however, no recent series have investigated its frequency, associated factors, and evolution.
Arturo Gonzalez Quintela +3 more
doaj +1 more source
Thrombocytopenia in pregnancy: is this immune thrombocytopenia or…? [PDF]
Hematology, 2012 Abstract Thrombocytopenia is a common finding in pregnancy. Establishing the diagnosis of immune thrombocytopenia (ITP) in a pregnant patient is similar to doing so in a nonpregnant patient, except that the evaluation must specifically rule out other disorders of pregnancy associated with low platelet counts that present different risks ...
openaire +2 more sources
Thrombocytopenia in pregnancy [PDF]
Postgraduate Medical Journal, 1992 Thrombocytopenia is defined as a platelet count of less than 150 x 109/l. Normal pregnancy is generally thought not to affect the platelet count,' but it has been suggested that the normal range is lower in pregnancy, and that the count falls in the third trimester.2`4 This review concentrates on causes of thrombocytopenia with particular reference to ...
openaire +2 more sources
Hematology, 2010 Immune thrombocytopenia (ITP) comprises a heterogeneous group of disorders characterized by autoimmune-mediated platelet destruction and impairment of thrombopoiesis. ITP may occur in the absence of an evident predisposing etiology (primary ITP) or secondary to a growing list of associated conditions (secondary ITP), and must be differentiated from ...
Adam, Cuker, Douglas B, Cines
openaire +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/
Sem A. O. F. Rikken +4 more
doaj +1 more source
Pattern Analysis of Thrombocytopenia in Dengue versus Non-Dengue Patients [PDF]
National Journal of Laboratory Medicine, 2018 Introduction: Dengue fever is one of the most prevalent and fastest spreading mosquito-borne arboviral infection occurring in tropical and sub-tropical regions around the world and leads to explosive outbreaks in urban areas influenced strongly by ...
Smitha Bhaskar +6 more
doaj +1 more source
Treatment of drug-induced immune thrombocytopenias
Haematologica, 2022 Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct toxicity of drug molecules to platelets or megakaryocytes.
Irene Marini +3 more
doaj +1 more source
Prognostic value of thrombocytopenia during hospitalizations in intracerebral hemorrhage patients
Frontiers in NeurologyBackgroundThe thrombocytopenia influences prognoses of critically ill patients. There are few studies exploring the prognostic value of thrombocytopenia among ICH patients.
Hao Feng +4 more
doaj +1 more source
Thrombocytopenia as a Clinical Biomarker of Retinopathy of Prematurity
Folia Medica Indonesiana, 2023 Highlights: • This is the first systematic review investigating thrombocytopenia and its association with retinopathy of prematurity. • Thrombocytopenia can be a useful clinical biomarker in retinopathy of prematurity screening, considering the quick,
I Wayan Eka Sutyawan +4 more
doaj +1 more source